Correction of coagulation and inflammation activation by chronic blood transfusion in an asplenic patient with haemoglobin E/β-thalassaemia and pulmonary arterial hypertension

Transfusion Medicine

Volumn 23, Issue 4, 2013, Pages 276-278

  Chuncharunee, S ^a   Atichartakarn, V ^a   Archararit, N ^a   Aryurachai, K ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; DEFEROXAMINE MESYLATE; FERRITIN; HEMOGLOBIN; HEPARIN; HYDROXYUREA; VASCULAR CELL ADHESION MOLECULE 1; WARFARIN; HEMOGLOBIN E;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD CLOTTING; BLOOD TRANSFUSION; CASE REPORT; CHOLECYSTECTOMY; DRUG DOSE INCREASE; FEMALE; FERRITIN BLOOD LEVEL; HEART CATHETERIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; INTERNATIONAL NORMALIZED RATIO; LIVER SIZE; LOW DRUG DOSE; MONONUCLEAR PHAGOCYTE; PROTHROMBIN TIME; PULMONARY HYPERTENSION; QUALITY OF LIFE; SPLENECTOMY; BETA-THALASSEMIA; COMPLICATION; HYPERTENSION, PULMONARY; INFLAMMATION;

ADULT; BETA-THALASSEMIA; BLOOD COAGULATION; BLOOD TRANSFUSION; FEMALE; HEMOGLOBIN E; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION;

EID: 84880580709     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12025     Document Type: Article

References (10)

1. Atichartakarn, V., Angchaisuksiri, P., Aryurachai, K., Onpun, S., Chuncharunee, S., Thakkinstian, A. & Atamasirikul, K. (2002) Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β-thalassaemic patients. British Journal of Haematology, 118, 893-898.
2. Atichartakarn, V., Likittanasombat, K., Chuncharunee, S., Chandanamattha, P., Worapongpaiboon, S., Angchaisuksiri, P. & Aryurachai, K. (2003) Pulmonary arterial hypertension in previously splenectomized patients with β-thalassemic disorders. International Journal of Hematology, 78, 139-145.
3. Atichartakarn, V., Chuncharunee, S., Chandanamattha, P., Likittanasombat, K. & Aryurachai, K. (2004) Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/β-thalassemia patient. Blood, 103, 2844-2846.
4. Banyatsuppasin, W., Butthep, P., Atichartakarn, V., Thakkinstian, A., Archararit, N., Pattanapanyasat, K. & Chuncharunee, S. (2011) Activation of mononuclear phagocytes and its relationship to asplenia and phosphatidylserine exposing red blood cells in hemoglobin E/β-thalassemia patients. American Journal of Hematology, 86, 89-92.
5. Cogliandro, T., Derchi, G., Mancuso, L. et al. (2008) Guideline recommendations for heart complications in thalassemia major. Journal of Cardiovascular Medicine, 9, 515-525.
6. Esmon, C.T. (2003) Inflammation and thrombosis. Journal of Thrombosis and Haemostasis, 1, 1343-1348.
7. Gibbs, J.S.R. & Higenbottam, T.W. (2001) Recommendations on the management of pulmonary hypertension in clinical practice. Heart, 86 (Suppl. 1), i1-i13.
8. Hanai, H., Watanabe, F., Yamada, M. et al. (2004) Correlation of serum soluble TNF-α receptors I and II levels with disease activity in patients with ulcerative colitis. American Journal of Gastroenterology, 99, 1532-1538.
9. Liem, R.I., O'Gorman, M.R. & Brown, D.L. (2004) Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome. American Journal of Hematology, 76, 19-25.
10. Sakhalkar, V.S., Rao, S.P., Weedon, J. & Miller, S.T. (2004) Elevated plasma sVCAM-1 levels in children with sickle cell disease: impact of chronic transfusion therapy. American Journal of Hematology, 76, 57-60.